Cyanotech Corporation reported its fourth quarter and fiscal year 2025 earnings results, showing a steady growth in net sales and improvements in financial performance. For the fourth quarter, the company achieved net sales of $6.3 million, marking an increase of $330,000 or 5.5% compared to the same period last year. Annual net sales reached $24.2 million, up by $1.1 million or 5% from the previous fiscal year. The company's gross profit for the fourth quarter was $1.7 million, with a gross profit margin of 27.7%, significantly higher than the $675,000 gross profit and 11.3% margin recorded in the fourth quarter of fiscal year 2024. For the entire fiscal year, Cyanotech's gross profit amounted to $6.9 million, with a gross profit margin of 28.4%, compared to $5.9 million and a 25.8% margin last year. This improvement was driven by higher production volumes and increased efficiencies in production. Cyanotech also reported a shift in its product sales mix, with bulk spirulina and bulk astaxanthin products growing by 53% and 74%, respectively. However, this growth was partially offset by a 5% decline in packaged sales. The company is focused on expanding market awareness through strategic initiatives, including the hiring of a Head of Sales to deepen channel expansion. Looking ahead, Cyanotech plans to manage inventory levels carefully to meet the heightened demand for its products while maintaining a conservative approach to cash management.